“We will Assess how the commercialization of this substance fits in with our company model at Adastra in order to posture ourselves to guidance the demand from customers for a secure offer of copyright,” mentioned chief govt officer Michael Forbes in a very information release. The corporate told VICE News it wouldn't be commenting even further